Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
American Journal of Physiology. Endocrinology and Metabolism|September 10, 2002
Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-deltaTony K T Lam, Hidenori Yoshii, C Andrew Haber, et al.American Journal of Physiology. Endocrinology and Metabolism|April 5, 2003
Mechanisms of the free fatty acid-induced increase in hepatic glucose productionTony K T Lam, André Carpentier, Gary F Lewis, et al.Journal of Vascular Research|February 11, 2010
Insulin inhibits and oral sucrose increases neointimal growth after arterial injury in ratsDanna M Breen, Jiwanjeet K Dhaliwall, Kalam K Chan, et al.Nutrition & Diabetes|March 21, 2019
Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivoTejas Desai, Khajag Koulajian, Aleksandar Ivovic, et al.Diabetes Technology & Therapeutics|February 12, 2015
In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin deliveryMichael K L Chu, Claudia R Gordijo, Jason Li, et al.American Journal of Physiology. Endocrinology and Metabolism|June 12, 2003
N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stressC Andrew Haber, Tony K T Lam, Zhiwen Yu, et al.Drug Delivery and Translational Research|March 8, 2021
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia preventionAmin GhavamiNejad, Brian Lu, Melisa Samarikhalaj, et al.Circulation|April 2, 2003
Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blockerChao-Hung Wang, Nathalie Leung, Nathalie Lapointe, et al.The Journal of Clinical Endocrinology and Metabolism|May 5, 2016
Longitudinal Associations of Phospholipid and Cholesteryl Ester Fatty Acids With Disorders Underlying DiabetesLuke W Johnston, Stewart B Harris, Ravi Retnakaran, et al.Journal of Lipid Research|July 11, 2018
Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetesLuke W Johnston, Zhen Liu, Ravi Retnakaran, et al.Pageof 13